Billable / Specific Code
ICD-10-CM T46.8X5 is the diagnosis code for Adverse effect of antivaricose drugs, including sclerosing agents. This code falls under the section "Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances" within Chapter 19 — Injury, poisoning and certain other consequences of external causes (S00-T88). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where T46.8X5 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, T46.8X5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
T46.8X5 is the ICD-10-CM diagnosis code for "Adverse effect of antivaricose drugs, including sclerosing agents". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of T46.8X5 is T46.8X ("Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents"). T46.8X5 provides a more specific classification within this category.
T46.8X5 is located in Section T36-T50 — "Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances" within Chapter 19 of the ICD-10-CM Tabular List.
Use T46.8X5 when the patients documented diagnosis matches "Adverse effect of antivaricose drugs, including sclerosing agents" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Adverse effect of antivaricose drugs, including sclerosing agents is T46.8X5.
Yes, T46.8X5 can be used as a primary diagnosis code since it is billable and specific.
T46.8X5 is in Chapter 19 of the ICD-10-CM Tabular List.
Yes, T46.8X5 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.